Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Topic's Include: Cases down, but Mayo Clinic expert says COVID-19 pandemic isn’t over, and community leaders and Mayo Clinic researchers develop playbook for COVID-19 health equity, future pandemics.
Today's Highlights Include: Reports Russian skater took banned drug trimetazidine puzzle experts, many Minneapolis employers rebooting return-to-office plans, and CDC expected to update mask guidance as early as next week.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Yasmeen Butt, M.D., Assistant Professor of Laboratory Medicine and Pathology, and Brittney Thiele, a medical student, both at Mayo Clinic’s Arizona campus, to discuss their Pathology Interest Group and the importance of having one.
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt consider how COVID-19 precautions may shift as the omicron surge ebbs, and how labs will adapt as the pandemic continues to change.
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the pediatric patient.
As director of Contract Administration, Cara Ryan’s work spans a diverse range of activities that connect with a variety of groups across the organization, all with a goal of supporting patient care.
This week’s research roundup features: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Topic's Include: Mayo Clinic in Rochester eases visitor restrictions for pediatric hospital patients, and ask the Mayo Mom: More than 2 years of COVID-19 takes its toll on children, families.
Today's Highlights Include: Biden officials trying to recalculate U.S. Covid-19 hospitalizations, CVS, Walgreens remove limits on at-home COVID-19 tests, and is it time to phase out masks in schools? Why more states and doctors are saying yes.
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss the importance of properly interpreting lab test results, and they review the crucial difference between screening tests and diagnostic tests.
Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.
February 8, 2022 Learn about the latest in laboratory compliance billing, including topics such as PAMA and COVID-19. This free webinar will review seven fundamental[...]